Literature DB >> 15557631

Rhodococcus equi-infected macrophages are recognized and killed by CD8+ T lymphocytes in a major histocompatibility complex class I-unrestricted fashion.

Kristin M Patton1, Travis C McGuire, Darrilyn G Fraser, Stephen A Hines.   

Abstract

The goal of this research was to examine the role of cytotoxic T lymphocytes (CTL) in the control of Rhodococcus equi and specifically to determine if R. equi-specific CD8+ CTL occurred in the blood of immune horses. Equine peripheral blood mononuclear cells stimulated with antigen-presenting cells either infected with R. equi or exposed to soluble R. equi antigen lysed R. equi-infected target cells. Lysis was decreased to background by depletion of either CD2+ or CD3+ cells, indicating that the effector cell had a T-lymphocyte, but not NK cell, phenotype. Stimulation induced an increased percentage of CD8+ T cells in the effector population, and depletion of CD8+ T cells resulted in significantly decreased lysis of infected targets. Killing of R. equi-infected macrophages by effector cells was equally effective against autologous and equine leukocyte antigen A (classical major histocompatibility complex [MHC] class I) mismatched targets. To evaluate potential target antigens, target cells were infected with either virulent (80.6-kb plasmid-containing) or avirulent (plasmid-cured) R. equi. The degree of lysis was not altered by the presence of the plasmid, providing evidence that the virulence plasmid, which is required for survival within macrophages, was not necessary for recognition and killing of R. equi-infected cells. These data indicate that immunocompetent adult horses develop R. equi-specific CD8+ CTL, which may play a role in immunity to R. equi. The apparent lack of restriction via classical MHC class I molecules suggests a novel or nonclassical method of antigen processing and presentation, such as presentation by CD1 or other nonclassical MHC molecules.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15557631      PMCID: PMC529141          DOI: 10.1128/IAI.72.12.7073-7083.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  49 in total

1.  A porcine cell surface receptor identified by monoclonal antibodies to SWC3 is a member of the signal regulatory protein family and associates with protein-tyrosine phosphatase SHP-1.

Authors:  B Alvarez; C Sánchez; R Bullido; A Marina; J Lunney; F Alonso; A Ezquerra; J Domínguez
Journal:  Tissue Antigens       Date:  2000-04

2.  DNA sequence and comparison of virulence plasmids from Rhodococcus equi ATCC 33701 and 103.

Authors:  S Takai; S A Hines; T Sekizaki; V M Nicholson; D A Alperin; M Osaki; D Takamatsu; M Nakamura; K Suzuki; N Ogino; T Kakuda; H Dan; J F Prescott
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

3.  Rhodococcus or mycobacterium? An example of misdiagnosis in HIV infection.

Authors:  J Macías; J A Pineda; F Borderas; J A Gallardo; J Delgado; M Leal; A Sánchez-Quijano; E Lissen
Journal:  AIDS       Date:  1997-02       Impact factor: 4.177

Review 4.  Role of cytotoxic cells in the protective immunity against and immunopathology of intracellular infections.

Authors:  T H Ottenhoff; T Mutis
Journal:  Eur J Clin Invest       Date:  1995-06       Impact factor: 4.686

5.  High frequencies of circulating IFN-gamma-secreting CD8 cytotoxic T cells specific for a novel MHC class I-restricted Mycobacterium tuberculosis epitope in M. tuberculosis-infected subjects without disease.

Authors:  A A Pathan; K A Wilkinson; R J Wilkinson; M Latif; H McShane; G Pasvol; A V Hill; A Lalvani
Journal:  Eur J Immunol       Date:  2000-09       Impact factor: 5.532

6.  Role of CD4+, CD8+ and double negative T-cells in the protection of SCID/beige mice against respiratory challenge with Rhodococcus equi.

Authors:  T L Ross; G A Balson; J S Miners; G D Smith; P E Shewen; J F Prescott; J A Yager
Journal:  Can J Vet Res       Date:  1996-07       Impact factor: 1.310

7.  Demonstration of three DRB loci in a domestic horse family.

Authors:  D G Fraser; E Bailey
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

8.  Transfer of a CD4+ Th1 cell line to nude mice effects clearance of Rhodococcus equi from the lung.

Authors:  S T Kanaly; S A Hines; G H Palmer
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

9.  Cytokine modulation alters pulmonary clearance of Rhodococcus equi and development of granulomatous pneumonia.

Authors:  S T Kanaly; S A Hines; G H Palmer
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

Review 10.  CD1, tuberculosis, and the evolution of major histocompatibility complex molecules.

Authors:  K Shinkai; R M Locksley
Journal:  J Exp Med       Date:  2000-03-20       Impact factor: 14.307

View more
  10 in total

1.  Nonhealing wound due to Rhodococcus equi in an apparently immunocompetent patient, revealing CD8+ T-lymphocyte deficiency.

Authors:  Eric Denes; Dominique Peignon-Orsoni; François-Xavier Terrade
Journal:  J Clin Microbiol       Date:  2010-09-29       Impact factor: 5.948

2.  Early development of cytotoxic T lymphocytes in neonatal foals following oral inoculation with Rhodococcus equi.

Authors:  Seth P Harris; Melissa T Hines; Robert H Mealey; Debra C Alperin; Stephen A Hines
Journal:  Vet Immunol Immunopathol       Date:  2011-03-21       Impact factor: 2.046

3.  Experimental infection of neonatal foals with Rhodococcus equi triggers adult-like gamma interferon induction.

Authors:  Stephanie Jacks; Steeve Giguère; P Cynda Crawford; William L Castleman
Journal:  Clin Vaccine Immunol       Date:  2007-04-04

4.  Rhodococcus equi-specific cytotoxic T lymphocytes in immune horses and development in asymptomatic foals.

Authors:  Kristin M Patton; Travis C McGuire; Melissa T Hines; Robert H Mealey; Stephen A Hines
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

5.  In vivo expression of and cell-mediated immune responses to the plasmid-encoded virulence-associated proteins of Rhodococcus equi in foals.

Authors:  Stephanie Jacks; Steeve Giguère; John F Prescott
Journal:  Clin Vaccine Immunol       Date:  2007-02-14

6.  Cloning and large-scale expansion of epitope-specific equine cytotoxic T lymphocytes using an anti-equine CD3 monoclonal antibody and human recombinant IL-2.

Authors:  Robert H Mealey; Matt H Littke; Steven R Leib; William C Davis; Travis C McGuire
Journal:  Vet Immunol Immunopathol       Date:  2007-04-08       Impact factor: 2.046

7.  The equine CD1 gene family is the largest and most diverse yet identified.

Authors:  Robson G Dossa; Debra C Alperin; Melissa T Hines; Stephen A Hines
Journal:  Immunogenetics       Date:  2013-11-07       Impact factor: 2.846

8.  Experimental Rhodococcus equi and equine infectious anemia virus DNA vaccination in adult and neonatal horses: effect of IL-12, dose, and route.

Authors:  R H Mealey; D M Stone; M T Hines; D C Alperin; M H Littke; S R Leib; S E Leach; S A Hines
Journal:  Vaccine       Date:  2007-08-15       Impact factor: 3.641

9.  Lymphocytes and macrophages are infected by Theileria equi, but T cells and B cells are not required to establish infection in vivo.

Authors:  Joshua D Ramsay; Massaro W Ueti; Wendell C Johnson; Glen A Scoles; Donald P Knowles; Robert H Mealey
Journal:  PLoS One       Date:  2013-10-07       Impact factor: 3.240

10.  Vaccination of mice with salmonella expressing VapA: mucosal and systemic Th1 responses provide protection against Rhodococcus equi infection.

Authors:  Aline F Oliveira; Luciana P Ruas; Silvia A Cardoso; Sandro G Soares; Maria-Cristina Roque-Barreira
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.